Cerebral catecholamines after levodopa therapy.
D000328:Adult; D000368:Aged; D001479:Basal Ganglia / Q000378:metabolism; D001921:Brain / Q000378:metabolism* / Q000473:pathology; D002395:Catecholamines / Q000378:metabolism*; D002540:Cerebral Cortex / Q000378:metabolism; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage / Q000627:therapeutic use*; D004298:Dopamine / Q000378:metabolism; D005260:Female; D006651:Histocytochemistry; D006801:Humans; D007031:Hypothalamus / Q000378:metabolism; D007231:Infant, Newborn; D008297:Male; D009638:Norepinephrine / Q000378:metabolism; D010300:Parkinson Disease / Q000188:drug therapy* / Q000473:pathology; D013378:Substantia Nigra / Q000378:metabolism
D002395:Catecholamines; D004295:Dihydroxyphenylalanine; D004298:Dopamine; D009638:Norepinephrine